期刊文献+

一种分离培养少突胶质前体细胞的改进方法 被引量:1

Improved method on isolation and culture of rat oligodendrocyte precursor cells
下载PDF
导出
摘要 目的:对少突胶质前体细胞的分离培养方法进行改良,为今后细胞移植治疗研究提供基础。方法:在大鼠少突胶质前体细胞分离纯化培养过程中添加不同浓度bFGF(5、10、20 ng/ml),显微镜观察少突胶质前体细胞在体外的生长情况,台盼蓝实验检测细胞存活率和获得率,免疫细胞化学技术进行细胞鉴定,流式细胞术检测细胞纯度。结果:在少突胶质前体细胞培养过程中添加10 ng/ml的bFGF,可明显提高少突胶质前体细胞的产出率和纯度。分离的少突胶质前体细胞呈A2B5、NG2阳性,能进一步分化为成熟少突胶质细胞且表达MBP和O4。结论:在培养中添加适当浓度的bFGF的方法能有效获得高纯度的少突胶质前体细胞。 Objective: To obtain healthier and purer oligodendrocyte precursor cells (OPCs) for the experiment of cell transplantation, the methods was modified in rat OPCs isolation and culture. Methods: Using bFGF of different concentra- tions ( 5, 10, 20 ng/ml) in the culture of OPCs, the growth pattern of OPCs in vitro was investigated by microscopy, cell survival rate and viable cell number were detected using trypan blue assay, cells were further identified with the immuno- fluorescent staining, and the purity of OPCs was detected by Flow cytometry. Results: Adding 10 ng/ml bFGF in OPC culture process, the purity and viable cell number were significantly improved. OPCs were immunoreactive with the spe- cific antibodies A2B5 and NG2. In addition, these OPCs progressively differentiated into mature oligedendrocytes which specifically expressed MBP and 04. Conclusion: The method adding moderate concentration of bFGF in the culture of OPCs, was suitable and effective to obtain OPCs in high purity .
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2013年第4期435-439,共5页 Chinese Journal of Neuroanatomy
基金 北京自然科学基金(5112027)
关键词 少突胶质前体细胞 BFGF 纯化 鉴定 细胞培养 OPCs bFGF purification identification cell culture
  • 引文网络
  • 相关文献

参考文献13

  • 1Asou H, Hamada K, Miyazaki T, et al. CNS myelinogenesis in vitro: time course and pattern of rat oligodendrocyte development [J]. J Neurosci Res, 1995, 40:519-534.
  • 2Nandoe Tewarie RS, Hurtado A, Bartels RH. Stem cell-based thera- pies for spinal cord injury[ J]. J Spinal Cord Med, 2009, 32:105 -114.
  • 3Hideyuki OKANO. Neural stem cells and strategies for the regenera- tion of the central nervous system[ J]. Proc Jpn Acad. 2010, B86: 438 - 451.
  • 4Targett MP, Sussman J, Scolding N, et al. Failureto achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain [ J ]. Neurpathol Appl Neurobiol, 1996, 22 : 199 - 206.
  • 5Zhao c, Fancy SP, Kotter MR, et al. Mechanisms of CNS remyeli- nation the key to therapeutic advances [ J ]. J Neurol sci, 2005, 233:87 -91.
  • 6Mahar A, Kim C, Wedemeyer M, et al. Short-segment fixation of lumbar burst fractures using pedicle fixtion at the level of the frac- ture[J]. Spine, 2007, 14:1503 - 1507.
  • 7Deng W, McKinnon RD, Poretz RD. Lead exposure delays the dif- ferentiation of oligodendroglial progenitors in vitrb. Toxicol Appl Pharrnacol, 2001. 174:235 - 244.
  • 8Givogri MI, Galbiati F, Fasano S, et al. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with meta- chromatic leukodystrophy [ J ]. J Neurosci, 2006, 26 : 3109 - 3119.
  • 9Stangel M and Hartung HP. Remyelinating strategies for the treat- ment of multiple sclerosis [ J ]. Prog Neurobiol, 2002, 68 : 361 - 376.
  • 10Yang Z, Watanabe M, Nishiyama A. Optimization of oligodendro- cyte progenitor cell culture method for enhanced survival [ J ]. J Neurosci Methods, 2005, 149:50-56.

同被引文献12

引证文献1

二级引证文献1

;
使用帮助 返回顶部